PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare that we ...
TMCnet

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

Applying HiFi sequencing as a first-tier assay is designed to consolidate and simplify the laboratory workflow especially in ...

PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome ...
Nasdaq

PacBio Develops New Method for Analyzing Complex Genome Regions Using Paraphase and HiFi Sequencing

PacBio has announced a new study published in Nature Communications that presents an innovative method for analyzing complex regions of the human genome, particularly segmental duplications that have ...
EurekAlert!

BacPhase: Long-insert paired-end sequencing for bin marker construction and genome phasing

In a paper published on aBIOTECH, the authors introduce BacPhase, a sequence-based phasing method that uses restriction ...